Ticaron-60 Tablet

Ticagrelor 60 mg

Ticaron-60 Tablet — Ticagrelor 60 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Ticagrelor 60 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 14 (Blister)
MRP ₹ 2800
Therapy Cardiac + Diabetic — Reversible direct-acting P2Y12 receptor antagonist
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Ticaron-60 Tablet

Ticaron-60 Tablet contains Ticagrelor 60 mg. Ticagrelor is a cyclopentyltriazolopyrimidine P2Y12 inhibitor — directly active (no metabolic activation needed) and reversibly bound, providing faster and more consistent platelet inhibition than clopidogrel.

Indicated for prevention of atherothrombotic events in acute coronary syndrome (PLATO trial — reduced CV death and MI vs clopidogrel) and long-term post-MI prevention (PEGASUS trial).

Camrut Healthcare manufactures the Ticaron range under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Acute coronary syndrome (STEMI/NSTEMI) with PCI or medical management
  • Long-term post-MI atherothrombotic event prevention
  • Adjunct to aspirin in dual antiplatelet therapy

Mechanism of Action

Ticagrelor reversibly binds the P2Y12 ADP receptor on platelets at a different site than thienopyridines, blocking ADP-mediated platelet activation. Faster onset, stronger and more consistent inhibition, with reversibility allowing faster recovery before surgery.

Dosage & Administration

['Loading dose: 180 mg (two 90 mg tablets) once at start of treatment', 'Maintenance: 90 mg twice daily for 12 months post-ACS', 'Long-term post-MI: 60 mg twice daily', 'Take with aspirin 75–100 mg daily']

Side Effects

['Bleeding (major and minor)', 'Dyspnoea (10–15%, usually mild, transient)', 'Bradycardia', 'Increased creatinine and uric acid', 'Hypersensitivity']

Contraindications & Precautions

['Active pathological bleeding', 'Recent intracranial bleeding', 'Severe hepatic impairment', 'Concurrent strong CYP3A4 inhibitors/inducers']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Ticaron-60 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.